Matthews Judith M. 4
4 · Iterum Therapeutics plc · Filed Mar 15, 2021
Insider Transaction Report
Form 4
Matthews Judith M.
Chief Financial Officer
Transactions
- Award
Restricted Share Units
2021-03-11+200,000→ 200,000 total→ Ordinary Shares (200,000 underlying)
Footnotes (2)
- [F1]Each restricted share unit ("RSU") represents the contingent right to receive one ordinary share upon vesting of the RSU.
- [F2]Subject to the reporting person providing continuous service to the Issuer on the relevant vesting date and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, the RSUs shall vest 50% on March 11, 2022 and 50% on March 11, 2023.